Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery.
about
Inflammatory bowel disease surgery in the biologic eraAnti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position PaperInfliximab's influence on anastomotic strength and degree of inflammation in intestinal surgery in a rabbit model.Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies.The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery.Variation in management of intra-abdominal abscesses in children with Crohn's disease.The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.Surgery for Crohn's disease and anti-TNF agents: the changing scenario.Prevention and management of nonhealing perineal woundsThe impact of peri-operative anti-TNF treatment on anastomosis-related complications in Crohn's disease patients. A critical review.Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis.European Society of Coloproctology consensus on the surgical management of intestinal failure in adults.Post-operative abdominal complications in Crohn's disease in the biological era: Systematic review and meta-analysis.Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.Short-term outcomes of laparoscopic surgery for Crohn's disease patients treated with anti-tumor necrosis factor alpha agents.Prognostic Nutritional Index Predicts Short-Term Postoperative Outcomes After Bowel Resection for Crohn's Disease.The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease.Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery.Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.Surgical Considerations in the Treatment of Small Bowel Crohn's Disease.Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.
P2860
Q26745627-B47B851F-B273-4EA8-A0D3-F2A87C2A0EB4Q26783978-4690AA69-B43F-426B-917C-8F7C415287E3Q33597698-8AFB2207-26C4-4F86-A384-D0CDBEC459CEQ35540491-0CF3DB90-BD27-4AD9-ADF9-2DA6EA6E1A66Q37197292-825608A9-4CDE-4746-A0EB-6A34AF778E52Q38085431-234B3D56-415B-4F1E-AB6F-67244D0706D7Q38087143-A4A6E6C8-ACDD-435C-BAC7-20B09CA2E824Q38098574-DF4EA546-140B-4F84-B470-3FFC37B281A8Q38155663-44927B3B-2F36-42EF-B6B7-09E9C3D53C26Q38179380-C8D4A44A-EC12-4152-B9A2-7B533083417DQ38193751-D1CC5C59-E2FB-4B38-BD70-18DFE180AB8DQ38725724-3834EDDE-4321-4DD5-A027-A9653A2381BAQ38762166-EFB372FA-AD9E-4478-B096-998287658FC3Q38791996-6198727F-AAF4-43CB-B242-8FAE6320EE34Q38820319-A7D9EDB0-BFE3-4F82-8DEA-00F54BD6A1D4Q38894023-C455D41A-927E-479B-9529-5275EB69A512Q39636883-3B514335-80D6-4AB3-9E69-E7C383F5F06CQ40561491-F3CAC1C8-174D-4F2A-B191-AA132E3FF9EAQ42202561-E552D360-294A-48C1-A70F-E57647D1E5D7Q42224687-A3B67692-2D59-4B45-8C01-11EF24A59F26Q42271558-19B75E8F-51BA-4B71-A849-075FA39C9072Q44607322-2367BF53-00B2-46EE-B35E-7BE30E3B3B83Q44775146-ED59112A-6EEF-4689-89D7-61991475064AQ46346648-7FB353B7-3158-4C03-9D16-BD18D0154E60Q50996989-C8123337-F6D7-4D9F-9C7A-CEB6DC9F996F
P2860
Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Infliximab does not affect pos ...... undergoing abdominal surgery.
@en
Infliximab does not affect pos ...... undergoing abdominal surgery.
@nl
type
label
Infliximab does not affect pos ...... undergoing abdominal surgery.
@en
Infliximab does not affect pos ...... undergoing abdominal surgery.
@nl
prefLabel
Infliximab does not affect pos ...... undergoing abdominal surgery.
@en
Infliximab does not affect pos ...... undergoing abdominal surgery.
@nl
P2093
P2860
P356
P1476
Infliximab does not affect pos ...... undergoing abdominal surgery.
@en
P2093
Andreas Bruckmeier
Florian Beigel
Karl-Walter Jauch
Mario H Müller
Martin E Kreis
Michael S Kasparek
Stephan Brand
Thomas Ochsenkühn
Ulrich Mansmann
P2860
P304
P356
10.1002/IBD.21860
P577
2011-09-16T00:00:00Z